SCHEMBL1452385

SCHEMBL1452385

[CH2]Cc1c[nH]c(N)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18955199 0.78 — —
SCHEMBL16579802 0.76 BACE1 (0.33) —
SCHEMBL9460184 0.76 — —
SCHEMBL5141263 0.76 — —
SCHEMBL365305 0.74 — —
Hydrochloric Acid SCHEMBL11228046 0.74 — —
Hydrochloric Acid SCHEMBL7957510 0.74 — —
Hydrochloric Acid SCHEMBL1518279 0.73 HRH4 (0.36) —
SCHEMBL5924432 0.73 — —
Hydrochloric Acid SCHEMBL4540563 0.73 HRH4 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910611-B2 Therapeutic agent for restenosis KYOWA HAKKO KIRIN CO., LTD. (JP) 2011-03-22 — — US disclosed
US-20100029625-A1 Therapeutic Agent for Restenosis KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-02-04 — — US disclosed
EP-1908755-A1 THERAPEUTIC AGENT FOR RESTENOSIS KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-04-09 — — EP disclosed
Send feedback